867MO Epigenetic therapy modulates the tumor microenvironment to sensitize anti-PD-1 refractory head and neck cancers to immunotherapy

Autor: Pai, S., Qin, T., Mattox, A., Campbell, J., Park, J.C., Shin, K-Y., Sadow, P., Faquin, W., Haddad, R., Pittet, M., Garris, C., Mempel, T., Oneill, A., Sartor, M.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S617-S617
Databáze: ScienceDirect